Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial

Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review

(2016) Samantha J. Broyd et al.   BIOLOGICAL PSYCHIATRY

Keep off the grass? Cannabis, cognition and addiction

(2016) H. Valerie Curran et al.   NATURE REVIEWS NEUROSCIENCE

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses

(2016) Will Lawn et al.   PSYCHOPHARMACOLOGY

Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males

(2016) C Mokrysz et al.   Translational Psychiatry

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

(2015) Chandni Hindocha et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Tobacco may mask poorer episodic memory among young adult cannabis users.

(2015) Randi M. Schuster et al.   NEUROPSYCHOLOGY

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study

(2014) Peggy van der Pol et al.   ADDICTION

Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children

(2014) S. H. Gage et al.   PSYCHOLOGICAL MEDICINE

Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’

(2012) Tom P. Freeman et al.   ADDICTION

Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function

(2012) Matthijs G. Bossong et al.   BIOLOGICAL PSYCHIATRY

Nicotine Fails to Attenuate Ketamine-Induced Cognitive Deficits and Negative and Positive Symptoms in Humans: Implications for Schizophrenia

(2012) Deepak Cyril D'Souza et al.   BIOLOGICAL PSYCHIATRY

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

(2012) Amir Englund et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers

(2012) S. De Simoni et al.   NEUROIMAGE

Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences

(2012) Natania A. Crane et al.   NEUROPSYCHOLOGY REVIEW

Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking

(2011) Islam Gamaleddin et al.   ADDICTION BIOLOGY

Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

(2010) Javier Fernández-Ruiz et al.   CNS Neuroscience & Therapeutics

Neurophysiological and cognitive effects of smoked marijuana in frequent users

(2010) Carl L. Hart et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Meta-analysis of the acute effects of nicotine and smoking on human performance

(2010) Stephen J. Heishman et al.   PSYCHOPHARMACOLOGY

Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts

(2009) Ziva D. Cooper et al.   DRUG AND ALCOHOL DEPENDENCE

The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

(2009) P. D. Morrison et al.   PSYCHOLOGICAL MEDICINE

Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis

(2009) J. Koskinen et al.   SCHIZOPHRENIA BULLETIN

Simultaneous cannabis and tobacco use and cannabis-related outcomes in young women

(2008) Arpana Agrawal et al.   DRUG AND ALCOHOL DEPENDENCE

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

(2008) JG Ramaekers et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

(2008) Deepak Cyril D'Souza et al.   NEUROPSYCHOPHARMACOLOGY

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)

(2008) Claudine C. Hunault et al.   PSYCHOPHARMACOLOGY

The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis

(2008) Oliver J. Mason et al.   SCHIZOPHRENIA RESEARCH

The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats

(2007) Mohammed Shoaib   NEUROPHARMACOLOGY